HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief: MAC's Miley Ad Ruffles Feathers; Cosmetic 'Scienceploitation'; More

This article was originally published in The Rose Sheet

Executive Summary

Scandalized Londoners take complaints about a MAC VIVA glam ad, featuring Miley Cyrus, to the Advertising Standards Authority; High Ridge Brands grows its hair-care portfolio with the acquisition of Salon Grafix; the American Society for Aesthetic Plastic Surgery says patients must be educated about stem cell-based cosmetic claims. More news in brief.

You may also be interested in...

Cosmetic News In Brief: High Ridge Brands Eyeing Acquisitions; Arbonne Eyeliner Recall; More

High Ridge Brands is on the lookout for acquisition opportunities to grow its branded personal-care portfolio, which includes Zest cleansers in North American markets and a number of hair-care brands, while Curology aims to expand its platform for direct-to-consumer prescription skin care with $15m in new funding. More news in brief.

ICCR Adds Cosmetic Product Preservation To Agenda For Ninth Meeting

During a public preparatory meeting in advance of the ninth International Cooperation for Cosmetics Regulation summit, FDA Office of Cosmetics and Colors Director Linda Katz said that the topic of cosmetic product preservation will be included on the agenda for the first time. Animal-testing alternatives, allergens and trace impurities also are up for discussion, continuing regulators' work from last year on those topics.

‘Revolution’ Quelled? FDA Warns Firm For ReLuma Stem-Cell Claims

Claims promoting Cell Vitals’ ReLuma skin-care line render the products unapproved drugs, FDA asserts in a Nov. 24 warning letter. Marketed as “A Revolution in Stem Cell Skin Care,” the firm’s products feature cytokines and growth factors harvested from adult stem cells that send “grow and divide” signals to aging skin cells, the company says.

Related Content

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts